1018. Deputy Pádraig Rice asked the Minister for Health the current status of a pricing and reimbursement application (details supplied); and the expected date of a decision. [74469/26]
Parliamentary questions
Questions
TDs ask ministers questions to get answers on the record, most of them in writing. Here is every one asked in the 34th Dáil, by the department it went to and the subject heading it was filed under. How questions work
Browse the questions
Showing questions asked by Pádraig Rice under the heading Medicinal Products.
43 questions match, newest first.
1021. Deputy Pádraig Rice asked the Minister for Health the actions the HSE and Health Products Regulatory Authority are taking regarding a current supply shortage (details supplied). [74468/26]
1023. Deputy Pádraig Rice asked the Minister for Health the current status of a full health technology assessment (details supplied); the reason no outcome has been published in over two years; and the expected date for a reimbursement decision. [74466/26]
3331. Deputy Pádraig Rice asked the Minister for Health if there are any plans to fund biological drugs for the treatment of lupus; the status of two applications (details supplied); and if she will make a statement on the matter. [55812/26]
3631. Deputy Pádraig Rice asked the Minister for Health if she will meet with an organisation (details supplied) regarding implementing an early access scheme; and if she will make a statement on the matter. [57126/26]
3683. Deputy Pádraig Rice asked the Minister for Health the status of a drug reimbursement application (details supplied); the timeline being worked towards for a decision; and if she will make a statement on the matter. [57384/26]
3872. Deputy Pádraig Rice asked the Minister for Health further to Parliamentary Question No. 290 of 27 May 2026, to provide an update on the development of a sandboxed early access programme for rare diseases; if there has been any progress or developments since May; the timeline she is working towards; and if she will make a statement on the matter. [58074/26]
211. Deputy Pádraig Rice asked the Minister for Health if the consideration of skyclarys for the treatment of Friedreich's ataxia will be prioritised; the date on which the drug will be on the agenda for a meeting of the HSE Drugs Group; and if she will make a statement on the matter. [46123/26]
1017. Deputy Pádraig Rice asked the Minister for Health to provide an update on the position regarding a drug for people living with Duchenne muscular dystrophy (details supplied); the outcome of the HSE Drug’s Group meeting on 10 June 2026; and if she will make a statement on the matter. [45899/26]
2398. Deputy Pádraig Rice asked the Minister for Health further to Parliamentary Question No. 566 of 21 April 2026, to provide an update on an application for pricing and reimbursement (details supplied); if the company has submitted a proposal to the HSE’s corporate pharmaceutical unit; if the company has met with the HSE since making an offer; the steps being taken to urgently progress a decision on this applicatio…
290. Deputy Pádraig Rice asked the Minister for Health further to Parliamentary Question No. 1239 of 19 May 2026, to provide further details regarding the strategic partnership established with the pharmaceutical sector to develop an early access programme for rare diseases; the status of this work; the timeline she is working towards for operationalising this programme; and if she will make a statement on the matter…
1476. Deputy Pádraig Rice asked the Minister for Health the timeline for a decision regarding the reimbursement of a treatment (details supplied) for adults living with spinal muscular atrophy; and if she will make a statement on the matter. [40158/26]
1217. Deputy Pádraig Rice asked the Minister for Health the reason that a supplement (details supplied) has not been made available under the drugs payment scheme; the actions necessary for this supplement to be made eligible for reimbursement under the scheme; and if she will make a statement on the matter. [35192/26]
886. Deputy Pádraig Rice asked the Minister for Health further to Parliamentary Question No. 423 of 5 February 2026, the status of an application for pricing and reimbursement (details supplied); if the HSE is still considering this application; the projected timeline for a decision; and if she will make a statement on the matter. [28668/26]
3237. Deputy Pádraig Rice asked the Minister for Health further to Parliamentary Question No. 685 of 19 February 2026, if she is committed to implementing Ava's protocol, recommended by Cork City Coroner's office in 2024; if this recommendation will be examined by the Review of Access to Cannabis for Medical Use; and if she will make a statement on the matter. [26568/26]
462. Deputy Pádraig Rice asked the Minister for Health to provide a list of ICS–formoterol combination inhalers currently reimbursed under the general medical services (GMS) scheme, including whether they are approved for use as maintenance and reliever therapy (MART); and if she will make a statement on the matter. [23298/26]
463. Deputy Pádraig Rice asked the Minister for Health to estimate the annual cost to the State of extending reimbursement to provide ICS–formoterol combination inhalers, used as maintenance and reliever therapy (MART), to all children aged 12 to 17 years-of-age diagnosed with asthma; and if she will make a statement on the matter. [23299/26]
1855. Deputy Pádraig Rice asked the Minister for Health to respond to matters raised in correspondence (details supplied); if any of the specific actions outlined can, or will, be advanced; and if she will make a statement on the matter. [19307/26]
120. Deputy Pádraig Rice asked the Minister for Health to provide an update on the delivery of the programme for Government commitment to continue to extend access to free contraception; the work carried out to date; the timeline she is working towards in expanding the scheme; and if she will make a statement on the matter. [17723/26]
672. Deputy Pádraig Rice asked the Minister for Health the number of people on a waiting list for pre-exposure prophylaxis, by clinic; and the wait time to be offered a new appointment in each clinic, in tabular form. [13935/26]
673. Deputy Pádraig Rice asked the Minister for Health to list all public pre-exposure prophylaxis clinics; and to identify the sites in which waiting lists are closed to new self-referrals, in tabular form. [13936/26]
674. Deputy Pádraig Rice asked the Minister for Health the funding allocated to public pre-exposure prophylaxis services to expand capacity, reduce waiting lists and ensure that the waiting lists in all public clinics are open to new self-referrals; and if she will make a statement on the matter. [13937/26]
675. Deputy Pádraig Rice asked the Minister for Health if a new model of pre-exposure prophylaxis will be considered, given the strain on existing clinics (details supplied); if she will review this model; and if she will make a statement on the matter. [13938/26]
1190. Deputy Pádraig Rice asked the Minister for Health the current reimbursement arrangements in place for GLP-1 medications; to identify the products currently available under each scheme and the criteria for access; if there are plans to expand access; if further products are undergoing pricing and reimbursement assessment; if so, the status of that work; and if she will make a statement on the matter. [10332/26]
217. Deputy Pádraig Rice asked the Minister for Health if a new agreement with respect to the pricing and supply of medicines contains any provisions which would see the procurement and use of pharmaceuticals manufactured by a company (details supplied) discontinued where alternatives exist; if not, to state whether this agreement will lead to an increase in the procurement of pharmaceuticals manufactured by this com…